Overview

Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the PK properties of lorcaserin in subjects with end stage renal disease (ESRD) who require dialysis and will be studied under dialysis and non-dialysis conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Arena Pharmaceuticals
Eisai Inc.